Black Rock Inc. Volitionrx LTD Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Volitionrx LTD stock. As of the latest transaction made, Black Rock Inc. holds 573,760 shares of VNRX stock, worth $349,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares

573,760

Previous 576,924 0.55%

Holding current value

$349,993

Previous $415,000 5.06%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.72 - $1.19 $2,278 - $3,765	-3,164 Reduced 0.55%	573,760 $436,000
Q4 2023 Feb 13, 2024	BUY	$0.55 - $0.88 $13,387 - $21,420	24,341 Added 4.4%	576,924 $415,000
Q3 2023 Nov 13, 2023	SELL	$0.69 - $1.53 $10,655 - $23,627	-15,443 Reduced 2.72%	552,583 $381,000
Q2 2023 Aug 11, 2023	BUY	$1.39 - $2.02 $28,103 - $40,840	20,218 Added 3.69%	568,026 $789,000
Q1 2023 May 12, 2023	BUY	$1.54 - $2.68 $10,336 - $17,988	6,712 Added 1.24%	547,808 $1.05 Million

Q4 2022 Feb 13, 2023	BUY	$1.63 - $2.6 $5,145 - $8,208	3,157 Added 0.59%	541,096 $1.31 Million
Q3 2022 Nov 14, 2022	SELL	$1.57 - $2.38 $4,045 - $6,133	-2,577 Reduced 0.48%	537,939 $732,000
Q2 2022 Aug 12, 2022	SELL	$1.96 - $3.05 $14,398 - $22,405	-7,346 Reduced 1.34%	540,516 $1.11 Million
Q1 2022 May 12, 2022	BUY	$2.41 - $3.24 $13,602 - $18,286	5,644 Added 1.04%	547,862 $1.65 Million
Q4 2021 Feb 10, 2022	BUY	$3.02 - $4.13 $14,698 - $20,100	4,867 Added 0.91%	542,218 $1.7 Million
Q3 2021 Nov 09, 2021	SELL	$2.98 - $3.48 $42,700 - $49,864	-14,329 Reduced 2.6%	537,351 $1.67 Million
Q2 2021 Aug 11, 2021	BUY	$3.01 - $3.78 $1.66 Million - $2.09 Million	551,680 New	551,680 $1.82 Million

Others Institutions Holding VNRX

# of Institutions

Shares Held

7.96M

Call Options Held

39K

Put Options Held

View Full List

About VOLITIONRX LTD

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $35M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

More about VNRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account